Venue
Convene
Convene, 201 Washington St, Boston, MA 02108, USA

What is Qwoted?

Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.

Event Date Mon Oct 7 EDT - Tue Oct 8 EDT (about 5 years ago)
Location Convene
201 Washington St, Boston, MA 02108, USA
Region Americas
Details

The LSX World Congress USA is a gathering of the industries foremost life science executive leaders.

Now in it’s second year, LSX USA follows the unique style and format of the LSX World Congress in London focusing on strategy, investment and partnering.

The three core pillars of our community are:

• CxOs of life sciences companies
• Heads of Pharma Business Development
• VC and PE Investors
• We address and look to find solutions to the respective challenges they face, and connect them with strategies, solutions and contacts to enable growth and development in their businesses.

Speakers

2019 Speakers

Laurent Audoly
President & CEO, Kymera Therapeutics

Jake Becraft
CEO, Strand Therapeutics

Jeff Behrens
President & CEO, Siamab Therapeutics

Laura Benjamin
Founder & CEO, Oncologie

David De Graaf
CEO, Comet Therapeutics

Peter Dudek
Partner, MRL Ventures Fund

Melissa Fensterstock
Co-Founder & CEO, Landsdowne Labs

Meredith Fisher
Partner, Partners Innovation Fund, Partners Healthcare

Todd Foley
Managing Partner, MPM Capital

John Glasspool
CEO, Anthos Therapeutics

Kelly Gold
VP, Corporate Development, CAMP4 Therapeutics

Dan Grau
CEO, Sojournix

Adam Houghton
VP & Head, AbbVie Ventures

Nouhad Husseini
VP, Head of Business Development, Regeneron Pharmaceuticals

Ed Kaye
CEO, Stoke Therapeutics

Nicole Bocskocsky
VP of Clinical Operations, Parsley Health

Philippe Lopes-Fernandes
VP, Global Head of BD & Alliance Management, Merck KGaA

Michael Pavia
CEO, Tuned Therapeutics

Veronique Riethuisen
SVP, Global Head of Business Development & Alliance Management, Ipsen

Priyanka Rohatgi
Managing Director, Head, Ipsen Ventures

Adam Rosenberg
President & CEO, Rodin Therapeutics

Nigel Sheail
Global Head of M&A & Business Development & Licensing, Novartis

Marshall Smith
Head of Global Healthcare, Goldman Sachs

Aaron Nelson
Principal, Novartis Venture Fund

Ricky Sun
Partner, Life Sciences, Bain Capital

Ted Tanner Jr.
CTO & Chief Architect, Watson Health, IBM

Rogerio Vivaldi
CEO, Sigilon Therapeutics

Alex Bargar
VP of Clinical Services, Simple Contacts

Carolyn Witte
Co-Founder & CEO, Tia

Beyhan Zaim
SVP, Commercial Business Development, Novo Nordisk

Alan Crane
Entrepreneur Partner, Polaris Partners

Joshua Resnick
Managing Partner, RA Capital Management

Christine Swenson
Regulatory Affairs, Moderna Therapeutics

Andrew ElBardissi
Principal, Deerfield Management

Martin Driscoll
President & CEO, Spring Bank Pharmaceuticals

Neal Farber
CEO, NeuroHealing Pharmaceuticals

Ailis Tweed-Kent
CEO, Cocoon Biotech

Alexandra Glücksmann
CEO, Cedilla Therapeutics

Kenneth Barr
SVP, Head of Discovery Services, Syngene

Satish Sanan
Chairman and CEO, Inspirata, Inc.

Deanna Petersen
CBO, AvroBio

Laurie Smaldone Alsup
MD, CSO, NDA Group

Constantine Chinoporos
CBO, Boston Pharmaceuticals

Derek Stoldt
Co-head, M&A & Life Sciences Transactions Practice, Arnold & Porter

Ori Solomon
Partner, Corporate Department & Co-chair, Emerging Companies & Venture Capital, Morrison Foerster

John Hodgson
Director, PersComm Ltd.

Donna LaVoie
President & CEO, LaVoie Health Science
LaVoie Health Science

Laura Tadvalkar, Principal, MP Healthcare Venture Management

Laura Tadvalkar
Principal, MP Healthcare Venture Management

Aradhana Sarin
Chief Strategy & Business Officer, Alexion Pharmaceuticals

Patrick Jordan
CEO, Mycovia

Anne Whitaker
CEO & Director, Dance Biopharm

Christopher Stepanian
CEO, WindGap Medical

Mark R. Fitzgerald
Partner, Wilson Sonsini Goodrich & Rosati

James Sietstra
CBO & Co-Founder, Totient, Inc.

Sharon Choe
SVP, IR & Business Development, LaVoie Health Science

Jay Margolis
VP & GM, Strategy & Portfolio Planning, IQVIA

Thomas Goodin
Senior Director, Clinical Development, Sunovion Pharmaceuticals Inc.

Darin DeCarlo
Sr Principal & Segment Lead, IQVIA

Sponsors & Partners

2019 Sponsors and Partners

PLATINUM PARTNERS:
• Goldman Sachs
• IQVIA

GOLD PARTNERS:
• Arnold & Porter
• Freshfields Bruckhaus Deringer
• Longevity Leaders
• Morrison & Foerster LLP
• NDA Group
• WSGR

SILVER SPONSOR:
• Syngene

SUPPORTING PARTNERS:
• Cambridge Innovation Center
• Freemind
• FTI Consulting
• LaVoieHealthScience
• Life Sciences Corridor
• Massachusetts Life Sciences Center
• MassBio
• Zyme Communications